Pharmacokinetics differences in risperidone and 9-OH risperidone: relation to inserted depth of injection needle in the people with schizophrenia who treated with regularly risperidone long acting injection (RLAI).
Not Applicable
- Conditions
- Schizophrenia
- Registration Number
- JPRN-UMIN000012301
- Lead Sponsor
- Okehazama Hospital Fujita Kokoro Care Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients meeting any of the following criteria will be excluded from the study. 1) PANSS total score over 130 points. 2) Patients who need to be treated with risperidone or paliperidone during this research.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method